Skip to main content
. 2024 Nov 2;8:249. doi: 10.1038/s41698-024-00727-2

Fig. 4. Platinum sensitivity scores.

Fig. 4

A Mean platinum sensitivity score (PSS) between primary, non-lymph metastatic, and lymph metastatic tumors (p > 0.05) (arbitrary units: AU). B Mean PSS score in chemo naïve tumors ± platinum-resistant alteration (defined as Mt-KRAS, Mt-TP53, Mt-KIT, or CNA-MDM2. Any tumors with CNA-KRAS alteration were not considered as part of the PRA group as tumors with these mutations tended to have higher PSS scores).